» Articles » PMID: 26123861

Predicting Early Death Among Elderly Dialysis Patients: Development and Validation of a Risk Score to Assist Shared Decision Making for Dialysis Initiation

Overview
Journal Am J Kidney Dis
Specialty Nephrology
Date 2015 Jul 1
PMID 26123861
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

Background: A shared decision-making tool could help elderly patients with advanced chronic kidney disease decide about initiating dialysis therapy. Because mortality may be high in the first few months after initiating dialysis therapy, incorporating early mortality predictors in such a tool would be important for an informed decision. Our objective is to derive and validate a predictive risk score for early mortality after initiating dialysis therapy.

Study Design: Retrospective observational cohort, with development and validation cohorts.

Setting & Participants: US Renal Data System and claims data from the Centers for Medicare & Medicaid Services for 69,441 (aged ≥67 years) patients with end-stage renal disease with a previous 2-year Medicare history who initiated dialysis therapy from January 1, 2009, to December 31, 2010.

Candidate Predictors: Demographics, predialysis care, laboratory data, functional limitations, and medical history.

Outcomes: All-cause mortality in the first 3 and 6 months.

Analytical Approach: Predicted mortality by logistic regression.

Results: The simple risk score (total score, 0-9) included age (0-3 points), low albumin level, assistance with daily living, nursing home residence, cancer, heart failure, and hospitalization (1 point each), and showed area under the receiver operating characteristic curve (AUROC)=0.69 in the validation sample. A comprehensive risk score with additional predictors was also developed (with AUROC=0.72, high concordance between predicted vs observed risk). Mortality probabilities were estimated from these models, with the median score of 3 indicating 12% risk in 3 months and 20% in 6 months, and the highest scores (≥8) indicating 39% risk in 3 months and 55% in 6 months.

Limitations: Patients who did not choose dialysis therapy and did not have a 2-year Medicare history were excluded.

Conclusions: Routinely available information can be used by patients with chronic kidney disease, families, and their nephrologists to estimate the risk of early mortality after dialysis therapy initiation, which may facilitate informed decision making regarding treatment options.

Citing Articles

Dialysis in the Elderly: A Practical Guide for the Clinician.

Satish A, Agrohi J, Rangaswamy D, Prabhu R, Nagaraju S, Rao I Int J Nephrol. 2025; 2025:9538115.

PMID: 40034192 PMC: 11872294. DOI: 10.1155/ijne/9538115.


Mortality Risk Prediction Models for People With Kidney Failure: A Systematic Review.

Jarrar F, Pasternak M, Harrison T, James M, Quinn R, Lam N JAMA Netw Open. 2025; 8(1):e2453190.

PMID: 39752155 PMC: 11699530. DOI: 10.1001/jamanetworkopen.2024.53190.


Predicting early mortality in hemodialysis patients: a deep learning approach using a nationwide prospective cohort in South Korea.

Noh J, Park S, Bae W, Kim K, Cho J, Lee J Sci Rep. 2024; 14(1):29658.

PMID: 39609495 PMC: 11604665. DOI: 10.1038/s41598-024-80900-6.


PTH may predict early mortality in incident patients on hemodialysis: results from a large cohort.

Aquino H, Canziani M, Barra A, Roque-da-Silva A, Strogoff-de-Matos J, Dalboni M Int Urol Nephrol. 2024; 57(2):545-551.

PMID: 39222240 DOI: 10.1007/s11255-024-04188-1.


External validation of the 2-year mortality prediction tool in hemodialysis patients developed using a Bayesian network.

Granal M, Brokhes-Le Calvez S, Dimitrov Y, Chantrel F, Borni-Duval C, Muller C Clin Kidney J. 2024; 17(6):sfae095.

PMID: 38915433 PMC: 11195611. DOI: 10.1093/ckj/sfae095.


References
1.
Keane W, Collins A . Influence of co-morbidity on mortality and morbidity in patients treated with hemodialysis. Am J Kidney Dis. 1994; 24(6):1010-8. DOI: 10.1016/s0272-6386(12)81076-6. View

2.
Feldman H, Kobrin S, Wasserstein A . Hemodialysis vascular access morbidity. J Am Soc Nephrol. 1996; 7(4):523-35. DOI: 10.1681/ASN.V74523. View

3.
Bang H, Edwards A, Bomback A, Ballantyne C, Brillon D, Callahan M . Development and validation of a patient self-assessment score for diabetes risk. Ann Intern Med. 2009; 151(11):775-83. PMC: 3633111. DOI: 10.7326/0003-4819-151-11-200912010-00005. View

4.
Davison S . End-of-life care preferences and needs: perceptions of patients with chronic kidney disease. Clin J Am Soc Nephrol. 2010; 5(2):195-204. PMC: 2827591. DOI: 10.2215/CJN.05960809. View

5.
Tangri N, Kent D . Toward a modern era in clinical prediction: the TRIPOD statement for reporting prediction models. Am J Kidney Dis. 2015; 65(4):530-3. DOI: 10.1053/j.ajkd.2014.12.005. View